Temozolomide treatment of an adult with a relapsing medulloblastoma

Cancer Investigation

Volumn 25, Issue 6, 2007, Pages 470-475

  Durando, X ^a   Thivat, Emilie ^a,b   Gilliot, Olivier ^a   Irthum, Bernard ^c   Verrelle, Pierre ^a   Vincent, Catherine ^a   Bay, Jacques Olivier ^a  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Medulloblastoma; Temozolomide

Indexed keywords

CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; CYTARABINE; ETOPOSIDE; GADOLINIUM; LOMUSTINE; METHYLPREDNISOLONE ACETATE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENT DISEASE; TREATMENT RESPONSE; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CEREBELLAR NEOPLASMS; DACARBAZINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 34548815696     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701518164     Document Type: Article

References (18)

1. Surawicz, T.S.; McCarthy, B.J.; Kupelian, V.; Jukich, P.J.; Bruner, J.M.; Davis, F.G. Descriptive epidemiology of primary brain and CNS tumors: results from the CentralBrain Tumor Registry of the United States, 1990-1994. Neuro-Oncol. 1999, 1 (1), 14-25.
2. Packer, R.J.; Cogen, P.; Vezina, G.; Rorke, L.B. Medulloblastoma: clinical and biologic aspects. Neuro-Oncol. 1999, 1 (3), 232-250.
3. Giordana, M.T.; Schiffer, P.; Schiffer, D. Prognostic factors in medulloblastoma. Childs Nerv Syst. 1998, 14 (6), 256-262.
4. Chang, C.H.; Housepian, E.M.; Herbert, C.J. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969, 93 (6), 1351-1359.
5. Merchant, T.E.; Wang, M.H.; Haida, T.; Lindsley, K.L.; Finlay, J.; et al. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. Int. J Radiat. Oncol. Biol. Phys. 1996, 36 (1), 29-35.
6. Gajjar, A.; Kuhl, J.; Epelman, S.; Bailey, C.; Allen, J. Chemotherapy of medulloblastoma. Childs Nerv. Syst. 1999, 15 (10), 554-562.
7. Kortmann, R.D.; Kuhl, J.; Timmermann, B.; Mittler, U.; Urban, C.; et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46 (2), 269-279.
8. Newton, H.B. Review of the molecular genetics and chemotherapeutic treatment of adult nd paediatric medulloblastoma. Expert. Opin. Investig. Drugs. 2001, 10 (12), 2089-2104.
9. Zeltzer, P.M.; Boyett, J.M.; Finlay, J.L.; Albright, A.L.; Rorke, L.B.; et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J. Clin. Oncol. 1999, 17 (3), 832-845.
10. Chintagumpala, M.; Berg, S.; Blaney, S.M. Treatment controversies in medulloblastoma. Curr. Opin. Oncol. 2001, 13 (3), 154-159.
11. Chinot, O. New place of the chemotherapy in gliomas. Bull. Cancer. 2005, 92 (4), 343-54.
12. Yung, W.K. Temozolomide in malignant gliomas. Semin. Oncol. 2000, 27 (3 Suppl. 6), 27-34.
13. Newlands, E.S.; Stevens, M.F.; Wedge, S.R.; Wheelhouse, R.T.; Brock, C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat. Rev. 1997, 23 (1), 35-61.
14. Yung, W.K.; Albright, R.E.; Olson, J.; Fredericks, R.; Fink, K.; et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer. 2000, 83 (5), 588-93.
15. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352 (10), 987-996.
16. O'Reilly, S.M.; Newlands, E.S.; Glaser, M.G.; Brampton, M.; Rice-Edwards, J.M.; et al. Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur. J. Cancer. 1993, 29A (7), 940-942.
17. Hongeng, S.; Visudtibhan, A.; Dhanachai, M.; Laothamatus, J.; Chiamchanya, S. Treatment of leptomeningeal relapse of medulloblastoma with temozolomide. J. Pediatr. Hematol. Oncol. 2002, 24 (7), 591-593.
18. Cefalo, G.; Ruggiero, A.; Abate, M.E.; Riccardi, R. High response rte totemozolomide in heavily pretreated children and young adults with medulloblastoma. Neuro-Oncol. 2002, 74 (Abstr 4:1).